Evidence map›Paper›PMID 31500407›Full record

ArticleACS synthetic biology2019

Sequence-Specific Mucins for Glycocalyx Engineering.

Hao Pan, Marshall J Colville, Nitin T Supekar, Parastoo Azadi, Matthew J Paszek

Open access · greenAbstract read
In one paragraph

Article in ACS synthetic biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthetic Antifreeze Glycoproteins with Potent Ice-Binding Activity.Chemistry of materials : a publication of the American Chemical Society · 2024
    Article
  4. Article
  5. Recombinant Production of Glycoengineered Mucins in HEK293-F Cells.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Recombinant mucin biotechnology and engineering.Advanced drug delivery reviews · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Glycocalyx Curving the Membrane: Forces Emerging from the Cell Exterior.Annual review of cell and developmental biology · 2021
    Review
  12. Modulation of immune cell reactivity withProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hao PanField of Biophysics , Cornell University , Ithaca , New York 14853 , United States.ORCID 0000-0001-9606-4188
Marshall J ColvilleField of Biophysics , Cornell University , Ithaca , New York 14853 , United States.ORCID 0000-0002-5397-8382
Nitin T SupekarComplex Carbohydrate Research Center , University of Georgia , Athens , Georgia 30602 , United States.
Parastoo AzadiComplex Carbohydrate Research Center , University of Georgia , Athens , Georgia 30602 , United States.
Matthew J PaszekField of Biophysics , Cornell University , Ithaca , New York 14853 , United States.
Cornell University · USUniversity of Georgia · US

Funding

Project 3: Physical and Metabolic Constraints of Cancer Cell InvasionU54CA210184 · NCI · CORNELL UNIVERSITY · PI SCHAFFER, CHRIS B · 2016 to 2020
$10.2M
TRAINING IN MOLECULAR PHYSICS OF BIOLOGICAL SYSTEMST32GM008267 · NIGMS · CORNELL UNIVERSITY ITHACA · PI WANG, MICHELLE D. · 1988 to 2021
$9.6M
Mechanobiology of the Cellular GlycocalyxDP2GM119133 · NIGMS · CORNELL UNIVERSITY · PI PASZEK, MATTHEW J · 2015 to 2015
$2.3M
Broad wavelength range Zeiss 780 NLO/confocal system for the Cornell Imaging CoreS10OD018516 · OD · CORNELL UNIVERSITY · PI ZIPFEL, WARREN R · 2014 to 2014
$834k
Orbitrap Fusion Tribrid Mass SpectrometerS10OD018530 · OD · UNIVERSITY OF GEORGIA · PI AZADI, PARASTOO · 2014 to 2014
$750k
NCI NIH HHS U54 CA210184NIGMS NIH HHS DP2 GM119133NIGMS NIH HHS T32 GM008267NIH HHS S10 OD018516NIH HHS S10 OD018530
6 · The paper itself

Abstract

Few approaches exist for the stable and controllable synthesis of customized mucin glycoproteins for glycocalyx editing in eukaryotic cells. Taking advantage of custom gene synthesis and a biology-by-parts approach to cDNA construction, we build a library of swappable DNA bricks for mucin leader tags, membrane anchors, cytoplasmic motifs, and optical reporters, as well as codon-optimized native mucin repeats and newly designed domains for synthetic mucins. We construct a library of over 50 mucins, each with unique chemical, structural, and optical properties and describe how additional permutations could readily be constructed. We apply the library to explore sequence-specific effects on glycosylation for engineering of mucins. We find that the extension of the immature α-GalNAc Tn-antigen to Core 1 and Core 2 glycan structures depends on the underlying peptide backbone sequence. Glycosylation could also be influenced through recycling motifs on the mucin cytoplasmic tail. We expect that the mucin parts inventory presented here can be broadly applied for glycocalyx research and mucin-based biotechnologies.

Indexed as

Antigens, Tumor-Associated, CarbohydrateCell LineCell Line, TumorGlycocalyxGlycosylationHEK293 CellsHumansMucinsAntigens, Tumor-Associated, CarbohydrateMucinsTn antigencustom gene synthesisengineeringglycanglycosylationmucinsynthetic biology

Identifiers

PMID31500407
PMCPMC7205180
OpenAlexW2973201818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.